Amphastar Pharmaceuticals, Inc. (AMPH) vs Phibro Animal Health Corporation (PAHC)
- Amphastar Pharmaceuticals, Inc. AMPH 25.87 −2.08%
- Phibro Animal Health Corporation PAHC 38.82 +2.21%
Amphastar Pharmaceuticals, Inc. and Phibro Animal Health Corporation are both Drug Manufacturers Specialty & Generic companies. Phibro Animal Health Corporation is the larger, with a market value of $1.5B against $1.1B — 1.4× the size. Amphastar Pharmaceuticals, Inc. trades at the lower P/E: 14.9× against 15.8×. Phibro Animal Health Corporation grew revenue faster over the last twelve months: 17.1% against 1.02%. Amphastar Pharmaceuticals, Inc. has the higher net margin (10.8% vs 6.57%) and the lower return on invested capital (6.57% vs 11.7%). Across the 22 metrics below, Amphastar Pharmaceuticals, Inc. leads on 14 and Phibro Animal Health Corporation on 8.
Valuation
Profitability
| Metric | AMPH | PAHC | Drug Manufacturers Specialty & Generic median |
|---|---|---|---|
| Gross margin | 47.68% | 33.76% | 53.94% |
| Operating margin | 15.66% | 12.81% | 0.00% |
| Net margin | 10.76% | 6.57% | 0.00% |
| Free cash flow margin | 20.94% | 0.65% | 0.00% |
| Return on equity | 10.30% | 29.72% | (0.40%) |
| Return on assets | 4.68% | 6.97% | (3.32%) |
| Return on invested capital | 6.57% | 11.72% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack